Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14516 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yusha Cui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Aims
Parkinsonian tremor (PT) is regulated by numerous neurophysiological components across multiple temporospatial scales. The dynamics of tremor fluctuation are thus highly complex. This study aimed to explore the effects of different medications on tremor complexity, and how the underlying factors contribute to such tremor complexity.
Methods
In this study, 66 participants received a 2‐mg dose of benzhexol or a pre‐determined dose of levodopa at two study visits in a randomized order. Before and after taking the medications, tremor fluctuation was recorded using surface electromyography electrodes and accelerometers in resting, posture, and weighting conditions with and without a concurrent cognitive task. Tremor complexity was quantified using multiscale entropy.
Results
Tremor complexity in resting ( p = 0.002) and postural condition ( p < 0.0001) was lower when participants were performing a cognitive task compared to a task‐free condition. After taking levodopa and benzhexol, participants had increased ( p = 0.02–0.03) and decreased ( p = 0.03) tremor complexity compared to pre‐medication state, respectively. Tremor complexity and its changes as induced by medications were significantly correlated with clinical ratings and their changes ( β = −0.23 to −0.39; p = 0.002–0.04), respectively.
Conclusion
Tremor complexity may be a promising marker to capture the pathophysiology underlying the development of PT, aiding the characterization of the effects medications have on PT regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, China.
- Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
- Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Roslindale, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Tao Feng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Cui, Y., Su, D., Zhang, J., Lam, J. S. T., Cao, S., Yang, Y., Piao, Y., Wang, Z., Zhou, J., Pan, H., & Feng, T. (2024). Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14516
Vancouver
Cui Y, Su D, Zhang J, Lam JST, Cao S, Yang Y, et al. Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14516
BibTeX
@article{Cui2024,
author = {Cui, Yusha and Su, Dongning and Zhang, Junjiao and Lam, Joyce S T and Cao, Shuangshuang and Yang, Yaqin and Piao, Yingshan and Wang, Zhan and Zhou, Junhong and Pan, Hua and Feng, Tao},
title = {Dopaminergic versus anticholinergic treatment effects on physiologic complexity of hand tremor in Parkinson's disease: A randomized crossover study},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14516}
}
EUVIMED